Notwithstanding, in their study of 48 patients with RA, Hasegawa et al. [18] found an improvement in total lean mass and a reduced percentage of patients with sarcopenia after 12 months’ therapy with TNF inhibitors. The gene discussed is TNF; the disease is sarcopenia.